Article
Alfuzosin improves both LUTS and sexual function
A once-daily dose of the uroselective alpha-1 blocker alfuzosin (Uroxatral),10 mg, significantly reduces lower urinary tract symptoms and also appearsto have a substantial positive effect on sexual function, according to datafrom a multinational study.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Anne Schuckman, MD, outlines current challenges in NMIBC care
Managing Abiraterone Intolerance: Alternative Dosing Strategies in Practice
Decision-Making and Multidisciplinary Counseling for Nodal Involvement on PSMA PET
Justin Dubin, MD, on the use of AI in the male infertility space
Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
Investigators compare trimodal therapy vs cystectomy in MIBC
Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
In the Pipeline: Novel Treatment Delivery Methods for NMIBC
Investigators assess ctDNA’s role in NMIBC
RX Review: Implementing mitomycin for LG-IR-NMIBC in clinical practice
Related Content
